Xcout Intel
SHS Capital
SHS Capital is a private equity investor specializing in the healthcare sector, providing growth capital and industry expertise to fast-growing healthcare and life sciences companies in Europe. The firm primarily targets small and medium-sized enterprises (SMEs) and scale-ups with equity tickets ranging from 10 to 50 million euros, supporting them through majority and minority investments.
Subscribe to see SHS Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SHS Capital at a glance
SHS Capital is a private equity company headquartered in Germany. Xcout tracks 10 named people at SHS Capital, including Lukas Maucher (Managing Partner, CFO).
SHS Capital leadership
- Lukas MaucherManaging Partner, CFO
- Manfred Ulmer-WeberManaging Partner
- Sascha AlilovicManaging Partner
- Uwe SteinbacherManaging Partner
- David WehnerPartner
- Dr. André ZimmermannPartner
4 more named people on record for SHS Capital, with roles, board committees and tenure — see the full roster →
SHS Capital competitors
A few of SHS Capital's closest competitors — see the full list of competitors and alternatives →
Silversmith Holdings is a growth equity firm that invests in technology and healthcare companies through long-term partnerships with entrepreneurs. The firm provides capital and collaborative support to help founders build and grow their businesses.
G Square Capital is a healthcare private equity investor that focuses on mid-market companies with high growth potential across Europe. The firm invests in four primary healthcare segments: medical products, healthcare IT, healthcare services, and services to the pharma industry.
Sherpa Healthcare Partners is a venture capital firm that invests in healthcare and life sciences innovation, focusing on sectors such as pharmaceuticals, gene technology, medical technology, and medical services. The company provides capital, strategic guidance, and resources to support the growth of early-stage and high-potential businesses in the healthcare industry.
Thuja Capital is an early-stage venture capital firm that invests in innovative life science companies located in Europe. The firm partners with visionary CEOs and leverages its sector expertise and industry network to help build healthcare businesses.
Ekkio Capital is an independent management company that invests in growing European small and medium-sized enterprises with revenues between 10 and 100 million euros. It provides long-term financial, strategic, and operational support across specific sectors, including tourism and leisure, health and beauty, security and control, and eco-responsibility.
Lauxera Capital Partners is an independent, international investment fund that targets growth-stage companies in the healthtech sector, including medical devices, digital health, and life science tools. The firm provides capital and expertise to help businesses achieve profitability and scale operations across Europe and the United States.
Get SHS Capital's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about SHS Capital? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SHS Capital in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access